» Articles » PMID: 35176222

Whole-genome Analysis of Human Embryonic Stem Cells Enables Rational Line Selection Based on Genetic Variation

Abstract

Despite their widespread use in research, there has not yet been a systematic genomic analysis of human embryonic stem cell (hESC) lines at a single-nucleotide resolution. We therefore performed whole-genome sequencing (WGS) of 143 hESC lines and annotated their single-nucleotide and structural genetic variants. We found that while a substantial fraction of hESC lines contained large deleterious structural variants, finer-scale structural and single-nucleotide variants (SNVs) that are ascertainable only through WGS analyses were present in hESC genomes and human blood-derived genomes at similar frequencies. Moreover, WGS allowed us to identify SNVs associated with cancer and other diseases that could alter cellular phenotypes and compromise the safety of hESC-derived cellular products transplanted into humans. As a resource to enable reproducible hESC research and safer translation, we provide a user-friendly WGS data portal and a data-driven scheme for cell line maintenance and selection.

Citing Articles

A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy.

Hirayama M, Hatou S, Nomura M, Hokama R, Hirayama O, Inagaki E Cell Rep Med. 2025; 6(1):101847.

PMID: 39809262 PMC: 11866429. DOI: 10.1016/j.xcrm.2024.101847.


NSD3 protein methylation and stabilization transforms human ES cells into variant state.

Krishnamoorthy V, Hamdani F, Shukla P, Rao R, Anaitullah S, Biligiri K Life Sci Alliance. 2024; 8(3.

PMID: 39741006 PMC: 11707394. DOI: 10.26508/lsa.202402871.


Gain of 1q confers an MDM4-driven growth advantage to undifferentiated and differentiating hESC while altering their differentiation capacity.

Krivec N, Couvreu de Deckersberg E, Lei Y, Al Delbany D, Regin M, Verhulst S Cell Death Dis. 2024; 15(11):852.

PMID: 39572522 PMC: 11582570. DOI: 10.1038/s41419-024-07236-x.


SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes.

Pierson Smela M, Pepe V, Lubbe S, Kiskinis E, Church G Stem Cell Reports. 2024; 19(10):1505-1515.

PMID: 39270651 PMC: 11561455. DOI: 10.1016/j.stemcr.2024.08.004.


De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture.

Al Delbany D, Ghosh M, Krivec N, Huyghebaert A, Regin M, Duong M Cells. 2024; 13(16).

PMID: 39195283 PMC: 11353044. DOI: 10.3390/cells13161395.


References
1.
Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S . Common genetic variation drives molecular heterogeneity in human iPSCs. Nature. 2017; 546(7658):370-375. PMC: 5524171. DOI: 10.1038/nature22403. View

2.
Merkle F, Eggan K . Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell. 2013; 12(6):656-68. DOI: 10.1016/j.stem.2013.05.016. View

3.
Merkle F, Maroof A, Wataya T, Sasai Y, Studer L, Eggan K . Generation of neuropeptidergic hypothalamic neurons from human pluripotent stem cells. Development. 2015; 142(4):633-43. PMC: 4325380. DOI: 10.1242/dev.117978. View

4.
Yang J, Lee S, Goddard M, Visscher P . GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2010; 88(1):76-82. PMC: 3014363. DOI: 10.1016/j.ajhg.2010.11.011. View

5.
Shihab H, Gough J, Cooper D, Day I, Gaunt T . Predicting the functional consequences of cancer-associated amino acid substitutions. Bioinformatics. 2013; 29(12):1504-10. PMC: 3673218. DOI: 10.1093/bioinformatics/btt182. View